Henry Schein consensus picture on Wall Street, shares in steady NASDAQ trade
Published on 06/30/2026 at 09:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:27.
Henry Schein (US42548G1040) starts this Tuesday with a stable picture on the NASDAQ. The focus for many investors is the current analyst consensus on the stock and the upcoming earnings date in the second half of the year.
What analysts currently say
Analyst coverage on Henry Schein centers on its role as a large distributor of dental and medical supplies in the United States and internationally. Typical consensus data from major platforms show a balanced rating mix with several Buy and Hold recommendations on the shares.
Major houses such as Goldman Sachs, JPMorgan and Morgan Stanley often appear in coverage lists for U.S. healthcare distributors, and Henry Schein is regularly compared with peers like Cardinal Health and McKesson in those reports. Price targets usually cluster around mid-double-digit dollar levels, reflecting moderate growth expectations in the dental and physician practice segments.
Upcoming earnings and calendar focus
Henry Schein reports results on a regular quarterly cycle, with its second and third quarter figures typically released in August and November. Investors watch these dates for updates on sales growth in dental supplies, technology solutions and medical distribution, as well as any changes to full-year guidance.
Consensus estimates around upcoming quarters tend to forecast single-digit to low double-digit percentage revenue growth, aligned with broader U.S. healthcare distribution trends. Margins in recent years have been relatively stable, supported by scale in distribution and an expanding offering of practice-management software and services.
Background and price data on Henry Schein
Further news and historical data on the Henry Schein shares can be found in the dedicated topic overview and on the company’s own Investor Relations pages.
What the company sells
Henry Schein generates most of its revenue by supplying dentists and physicians with everything from consumable materials to equipment and practice-management technology. A representative product area is dental supplies such as composite materials, impression materials and infection control products sold to practices worldwide.
Where the stock trades today
Henry Schein shares (US42548G1040) trade on the NASDAQ in New York, with the latest available price data showing a quotation in U.S. dollars on 2026-06-30, 09:27. The stock remains part of the broader U.S. healthcare sector universe with a mid-cap profile on that venue.
Key data on the Henry Schein shares
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Trading venue: NASDAQ
- Price (as of 2026-06-30, 09:27): not live-verifiable USD
- Market cap: mid-cap range in USD (as of 2026-06-30)
- Sector / industry: Health Care Equipment & Supplies / Distribution
- Index membership: component of major U.S. healthcare indices and sector benchmarks
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data are based on publicly available sources believed to be reliable but cannot be guaranteed for completeness or accuracy.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
